Now loading...
Motilal Oswal Financial Services recommended a buy on Piramal Pharma with a target price of Rs 300. The current price is Rs 233.4. Despite a quarterly income dip, the company anticipates growth in the CDMO/CHG segments. Piramal Pharma, a Small Cap company with Rs 30903.19 crore market cap, has notable top management and superior future estimates.
Now loading...